HEADER NUCLEAR PROTEIN 05-JUL-22 8DKN TITLE PPARG BOUND TO T0070907 AND CO-R PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES; COMPND 6 MOL_ID: 2; COMPND 7 MOLECULE: NUCLEAR RECEPTOR COREPRESSOR 1 PEPTIDE; COMPND 8 CHAIN: C; COMPND 9 SYNONYM: N-COR,N-COR1; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 MOL_ID: 2; SOURCE 9 SYNTHETIC: YES; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606 KEYWDS PPARG, INVERSE AGONIST, COVALENT, T007, NUCLEAR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR N.A.LARSEN,J.TSAI REVDAT 3 25-OCT-23 8DKN 1 REMARK REVDAT 2 05-APR-23 8DKN 1 JRNL REVDAT 1 07-SEP-22 8DKN 0 JRNL AUTH S.IRWIN,C.KARR,C.FURMAN,J.TSAI,P.GEE,D.BANKA,A.S.WIBOWO, JRNL AUTH 2 A.A.DEMENTIEV,M.O'SHEA,J.YANG,J.LOWE,L.MITCHELL,S.RUPPEL, JRNL AUTH 3 P.FEKKES,P.ZHU,M.KORPAL,N.A.LARSEN JRNL TITL BIOCHEMICAL AND STRUCTURAL BASIS FOR THE PHARMACOLOGICAL JRNL TITL 2 INHIBITION OF NUCLEAR HORMONE RECEPTOR PPAR GAMMA BY INVERSE JRNL TITL 3 AGONISTS. JRNL REF J.BIOL.CHEM. V. 298 02539 2022 JRNL REFN ESSN 1083-351X JRNL PMID 36179791 JRNL DOI 10.1016/J.JBC.2022.102539 REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0103 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 50.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 21756 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.230 REMARK 3 R VALUE (WORKING SET) : 0.227 REMARK 3 FREE R VALUE : 0.297 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1131 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.00 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1541 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.16 REMARK 3 BIN R VALUE (WORKING SET) : 0.4210 REMARK 3 BIN FREE R VALUE SET COUNT : 102 REMARK 3 BIN FREE R VALUE : 0.4780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2213 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 51 REMARK 3 SOLVENT ATOMS : 40 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 55.30 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.09000 REMARK 3 B22 (A**2) : -0.07000 REMARK 3 B33 (A**2) : -0.02000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.193 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.192 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.214 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 8.125 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.962 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.937 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2300 ; 0.015 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2294 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3095 ; 1.816 ; 2.015 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5294 ; 1.039 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 275 ; 7.524 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 98 ;36.241 ;25.408 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 435 ;17.319 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 9 ;18.120 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 359 ; 0.103 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2499 ; 0.008 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 485 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8DKN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-22. REMARK 100 THE DEPOSITION ID IS D_1000266845. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 19-MAR-16 REMARK 200 TEMPERATURE (KELVIN) : 120 REMARK 200 PH : 9-9.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 21-ID-D REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9786 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 300 MM PLATE REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22981 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.07700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.49600 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: MOLREP REMARK 200 STARTING MODEL: 2PRG REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 49.60 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.44 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2+2 UL DROPS MADE FROM A 2:2:1 MOLAR REMARK 280 RATIO OF T007:NCOR PEPTIDE:PPARG AND WELL SOLUTION CONTAINING REMARK 280 1.8-2.2 M (NH3)2SO4, 0.2 M LI2SO4 AND 100 MM CAPS PH 9.5. REMARK 280 PROTEIN FORMULATED AT 20 MG ML-1 IN 20 MM TRIS, PH 8.0, 100 MM REMARK 280 NACL, AND 1MM TCEP, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE REMARK 280 296K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.60400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.94500 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.60400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 40.94500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15060 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -18.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 233 REMARK 465 ILE A 290 REMARK 465 LYS A 291 REMARK 465 PHE A 292 REMARK 465 LYS A 293 REMARK 465 HIS A 294 REMARK 465 ILE A 295 REMARK 465 THR A 296 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 235 CG CD OE1 OE2 REMARK 470 LYS A 386 CG CD CE NZ REMARK 470 GLU A 488 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 THR A 269 138.75 -19.17 REMARK 500 LYS A 386 -119.74 60.58 REMARK 500 LYS A 432 -45.42 -152.22 REMARK 500 GLU A 488 88.71 -63.97 REMARK 500 THR A 489 157.75 -33.02 REMARK 500 LEU A 504 -156.48 -102.11 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LEU A 298 GLN A 299 -134.75 REMARK 500 ARG A 385 LYS A 386 148.76 REMARK 500 REMARK 500 REMARK: NULL DBREF 8DKN A 234 505 UNP P37231 PPARG_HUMAN 234 505 DBREF 8DKN C 2 14 UNP O75376 NCOR1_HUMAN 2260 2272 SEQADV 8DKN GLY A 233 UNP P37231 EXPRESSION TAG SEQRES 1 A 273 GLY PRO GLU SER ALA ASP LEU ARG ALA LEU ALA LYS HIS SEQRES 2 A 273 LEU TYR ASP SER TYR ILE LYS SER PHE PRO LEU THR LYS SEQRES 3 A 273 ALA LYS ALA ARG ALA ILE LEU THR GLY LYS THR THR ASP SEQRES 4 A 273 LYS SER PRO PHE VAL ILE TYR ASP MET ASN SER LEU MET SEQRES 5 A 273 MET GLY GLU ASP LYS ILE LYS PHE LYS HIS ILE THR PRO SEQRES 6 A 273 LEU GLN GLU GLN SER LYS GLU VAL ALA ILE ARG ILE PHE SEQRES 7 A 273 GLN GLY CYS GLN PHE ARG SER VAL GLU ALA VAL GLN GLU SEQRES 8 A 273 ILE THR GLU TYR ALA LYS SER ILE PRO GLY PHE VAL ASN SEQRES 9 A 273 LEU ASP LEU ASN ASP GLN VAL THR LEU LEU LYS TYR GLY SEQRES 10 A 273 VAL HIS GLU ILE ILE TYR THR MET LEU ALA SER LEU MET SEQRES 11 A 273 ASN LYS ASP GLY VAL LEU ILE SER GLU GLY GLN GLY PHE SEQRES 12 A 273 MET THR ARG GLU PHE LEU LYS SER LEU ARG LYS PRO PHE SEQRES 13 A 273 GLY ASP PHE MET GLU PRO LYS PHE GLU PHE ALA VAL LYS SEQRES 14 A 273 PHE ASN ALA LEU GLU LEU ASP ASP SER ASP LEU ALA ILE SEQRES 15 A 273 PHE ILE ALA VAL ILE ILE LEU SER GLY ASP ARG PRO GLY SEQRES 16 A 273 LEU LEU ASN VAL LYS PRO ILE GLU ASP ILE GLN ASP ASN SEQRES 17 A 273 LEU LEU GLN ALA LEU GLU LEU GLN LEU LYS LEU ASN HIS SEQRES 18 A 273 PRO GLU SER SER GLN LEU PHE ALA LYS LEU LEU GLN LYS SEQRES 19 A 273 MET THR ASP LEU ARG GLN ILE VAL THR GLU HIS VAL GLN SEQRES 20 A 273 LEU LEU GLN VAL ILE LYS LYS THR GLU THR ASP MET SER SEQRES 21 A 273 LEU HIS PRO LEU LEU GLN GLU ILE TYR LYS ASP LEU TYR SEQRES 1 C 13 ASN LEU GLY LEU GLU ASP ILE ILE ARG LYS ALA LEU MET HET EEY A 601 18 HET CXS A 602 14 HET CXS A 603 14 HET SO4 C 101 5 HETNAM EEY 2-CHLORO-5-NITRO-N-(PYRIDIN-4-YL)BENZAMIDE HETNAM CXS 3-CYCLOHEXYL-1-PROPYLSULFONIC ACID HETNAM SO4 SULFATE ION FORMUL 3 EEY C12 H8 CL N3 O3 FORMUL 4 CXS 2(C9 H19 N O3 S) FORMUL 6 SO4 O4 S 2- FORMUL 7 HOH *40(H2 O) HELIX 1 AA1 PRO A 234 PHE A 254 1 21 HELIX 2 AA2 THR A 257 GLY A 267 1 11 HELIX 3 AA3 ASP A 279 MET A 285 1 7 HELIX 4 AA4 GLN A 301 LYS A 303 5 3 HELIX 5 AA5 GLU A 304 SER A 317 1 14 HELIX 6 AA6 SER A 317 SER A 330 1 14 HELIX 7 AA7 ASP A 338 LEU A 361 1 24 HELIX 8 AA8 ARG A 378 LEU A 384 1 7 HELIX 9 AA9 PRO A 387 PHE A 391 5 5 HELIX 10 AB1 MET A 392 LEU A 405 1 14 HELIX 11 AB2 ASP A 408 LEU A 421 1 14 HELIX 12 AB3 LYS A 432 HIS A 453 1 22 HELIX 13 AB4 GLN A 458 LYS A 486 1 29 HELIX 14 AB5 HIS A 494 LYS A 502 1 9 HELIX 15 AB6 GLY C 4 MET C 14 1 11 SHEET 1 AA1 4 PHE A 275 ILE A 277 0 SHEET 2 AA1 4 GLY A 374 THR A 377 1 O PHE A 375 N ILE A 277 SHEET 3 AA1 4 GLY A 366 ILE A 369 -1 N ILE A 369 O GLY A 374 SHEET 4 AA1 4 MET A 362 ASN A 363 -1 N ASN A 363 O GLY A 366 LINK SG CYS A 313 C03 EEY A 601 1555 1555 1.64 CISPEP 1 THR A 489 ASP A 490 0 6.37 CRYST1 83.208 81.890 48.146 90.00 103.79 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012018 0.000000 0.002949 0.00000 SCALE2 0.000000 0.012212 0.000000 0.00000 SCALE3 0.000000 0.000000 0.021386 0.00000